As of August 28, 2026, Alnylam Pharmaceuticals, Inc. (ALNY) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Alnylam Pharmaceuticals, Inc. has a market capitalization of $40.32B, 133.81M shares outstanding, 796 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ALNY.
Market Data
Market Cap$40.32B
Shares Outstanding133.81M
Float132.95M
Cash$1.71B
Debt$677.72M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 2.8% shares (2026Q1 vs prior)
796 institutional holders · 144.53M shares
#1
FMR LLC
14.58M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
11.89M shares
#3
Capital World Investors
10.80M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest4.80M
Days to Cover2.2
% of Float3.6%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2025-12-31
3
FORM3
2026-04-07
4
INSIDER TRANSACTION
2026-03-06
4
INSIDER TRANSACTION
2026-03-04
4
INSIDER TRANSACTION
2026-03-04
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual ALNY Dilution Snapshot
Alnylam Pharmaceuticals, Inc. (ALNY) has a DilutionScore of 10/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for ALNY: 3 on 2026-04-07; 4 on 2026-03-06; 4 on 2026-03-04.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track ALNY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ALNY — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for ALNY
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.